← Back

EMA - European Medicines Agency · EU-wide · 13 Oct 2026 · News & press

EMA/FVE information session for veterinary students: the importance of pharmacovigilance

AI-generated summary

The EMA and Federation of Veterinarians of Europe offer an information session for veterinary students on pharmacovigilance in veterinary medicines. The session covers the role of veterinarians in reporting suspected adverse events, how safety reports support ongoing monitoring of authorized medicines, and the importance of post-authorization safety monitoring. Veterinarians are identified as key to identifying and reporting suspected adverse events from medicines in real-world use. The event is recorded and published online; registration requires consent to data processing under EU Regulation 2018/1725.

From EMA - European Medicines Agency

Veterinary students can join an information session hosted by EMA and the Federation of Veterinarians of Europe (FVE) on pharmacovigilance and its role in protecting animal health, public health and the environment.

Why pharmacovigilance matters

Veterinarians play a key role in monitoring the safety of veterinary medicines. As the trusted healthcare professionals closest to the animals and their owners and keepers, they are often the first to identify and report suspected adverse events associated with veterinary medicines.

These reports provide real-world evidence on how medicines perform in everyday use. They help identify new or emerging risks and support the safe and effective use of veterinary medicines.

What participants will learn

The session provides practical knowledge on:

- pharmacovigilance and veterinary medicines;

- the role of veterinarians in reporting suspected adverse events;

- how safety reports contribute to the ongoing monitoring of authorised medicines;

- the importance of post-authorisation safety monitoring.

Who should attend

The session is designed for veterinary students who want to understand their future role in maintaining the safety of veterinary medicines.

Registration

The event is recorded and the recording is published on this website. By registering for the event, you are consenting to EMA to process your data in accordance with Regulation (EU) 2018/1725.

For information on how personal data is processed by EMA, refer to:

European Medicines Agency’s data protection notice for meeting registration forms via Microsoft Forms

Excerpt from the official page. The original is authoritative.